Related Experiment Video
Updated: Jan 11, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Cerebral Aspergillosis: Diagnostic Challenges, Therapeutic Strategies, and Future Research
Louise Chantelot1, Emilie Sitterlé2, Sylvain Poirée3
1Infectious Diseases and Tropical Medicine Department, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France.
Abstract:
Cerebral aspergillosis is a well-recognized and particularly severe manifestation of invasive aspergillosis, primarily affecting immunocompromised individuals. The condition is associated with high morbidity and mortality, largely due to diagnostic challenges and limited treatment options. This review examines the epidemiology, risk factors, and diagnostic issues before focusing on drug treatment, including the pharmacokinetics and pharmacodynamics of antifungal agents in the central nervous system. Resistance to current antifungal therapies is also discussed, along with future research directions.
Insights
Cerebral aspergillosis, a severe fungal infection in immunocompromised patients, presents diagnostic challenges and limited treatments. This review covers its epidemiology, diagnostics, and antifungal drug therapies for the central nervous system.
Area of Science:
- * Neurology
- * Infectious Diseases
- * Mycology
Background:
- * Cerebral aspergillosis is a severe manifestation of invasive aspergillosis.
- * Primarily affects immunocompromised individuals, leading to high morbidity and mortality.
- * Diagnostic challenges and limited treatment options contribute to poor outcomes.
Purpose of the Study:
- * To review the epidemiology and risk factors of cerebral aspergillosis.
- * To examine diagnostic issues and current drug treatment strategies.
- * To discuss antifungal pharmacokinetics/pharmacodynamics in the CNS and emerging resistance.
Main Methods:
- * Comprehensive literature review of cerebral aspergillosis.
- * Analysis of epidemiological data and risk factors.
- * Evaluation of diagnostic modalities and antifungal therapies.
Main Results:
- * Cerebral aspergillosis epidemiology and risk factors are detailed.
- * Diagnostic challenges and their impact are highlighted.
- * Antifungal drug properties and resistance patterns in CNS infections are examined.
Conclusions:
- * Cerebral aspergillosis requires improved diagnostic and therapeutic approaches.
- * Understanding antifungal CNS penetration and resistance is crucial.
- * Further research is needed to address treatment gaps and improve patient outcomes.
More Related Videos
08:01Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021